127 related articles for article (PubMed ID: 20837664)
41. ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer.
Bakkenist CJ; Lee JJ; Schmitz JC
Clin Colorectal Cancer; 2018 Dec; 17(4):255-257. PubMed ID: 30316683
[No Abstract] [Full Text] [Related]
42. PinX1 without the G-patch motif suppresses proliferation, induces senescence, but does not inhibit telomerase activity in colorectal cancer SW480 cells.
Zhang R; Zhao J; Wang X; Wang LL; Xu J; Song C
Oncol Rep; 2014 Jul; 32(1):286-92. PubMed ID: 24839934
[TBL] [Abstract][Full Text] [Related]
43. Targeted Covalent Inhibition of Telomerase.
Betori RC; Liu Y; Mishra RK; Cohen SB; Kron SJ; Scheidt KA
ACS Chem Biol; 2020 Mar; 15(3):706-717. PubMed ID: 32017522
[TBL] [Abstract][Full Text] [Related]
44. Cell cycle-dependent modulation of telomerase activity in tumor cells.
Zhu X; Kumar R; Mandal M; Sharma N; Sharma HW; Dhingra U; Sokoloski JA; Hsiao R; Narayanan R
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6091-5. PubMed ID: 8650224
[TBL] [Abstract][Full Text] [Related]
45. PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase.
Mollazade M; Nejati-Koshki K; Akbarzadeh A; Zarghami N; Nasiri M; Jahanban-Esfahlan R; Alibakhshi A
Asian Pac J Cancer Prev; 2013; 14(11):6925-8. PubMed ID: 24377627
[TBL] [Abstract][Full Text] [Related]
46. Telomerase: an unusual target for cytotoxic agents.
Corey DR
Chem Res Toxicol; 2000 Oct; 13(10):957-60. PubMed ID: 11080041
[No Abstract] [Full Text] [Related]
47. Telomerase and cancer therapeutics.
Harley CB
Nat Rev Cancer; 2008 Mar; 8(3):167-79. PubMed ID: 18256617
[TBL] [Abstract][Full Text] [Related]
48. Complex regulation of telomerase activity: implications for cancer therapy.
Elenitoba-Johnson KS
Am J Pathol; 2001 Aug; 159(2):405-10. PubMed ID: 11485897
[No Abstract] [Full Text] [Related]
49. Helicases, G4-DNAs, and drug design.
Hale TK; Norris GE; Jameson GB; Filichev VV
ChemMedChem; 2014 Sep; 9(9):2031-4. PubMed ID: 24825788
[TBL] [Abstract][Full Text] [Related]
50. Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line.
Sharma S; Raymond E; Soda H; Izbicka E; Davidson K; Lawrence R; Von Hoff DD
Leuk Res; 1998 Aug; 22(8):663-70. PubMed ID: 9680092
[TBL] [Abstract][Full Text] [Related]
51. [The influence of compound aITEL1296 on telomerase activity and the growth of cancer cells].
Kovalenko NA; Zhdanov DD; Bibikova MV; Gotovtseva VIu
Biomed Khim; 2011; 57(5):501-10. PubMed ID: 22629600
[TBL] [Abstract][Full Text] [Related]
52. Anticancer agents: towards the future.
Palumbo M
Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):425-7. PubMed ID: 15379697
[TBL] [Abstract][Full Text] [Related]
53. Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more.
Sabisz M; Skladanowski A
Curr Pharm Biotechnol; 2008 Aug; 9(4):325-36. PubMed ID: 18691092
[TBL] [Abstract][Full Text] [Related]
54. Human telomerase inhibitors from microbial source.
Kiran KG; Palaniswamy M; Angayarkanni J
World J Microbiol Biotechnol; 2015 Sep; 31(9):1329-41. PubMed ID: 26130439
[TBL] [Abstract][Full Text] [Related]
55. Repair and translesion DNA polymerases as anticancer drug targets.
Maga G; Hübscher U
Anticancer Agents Med Chem; 2008 May; 8(4):431-47. PubMed ID: 18473728
[TBL] [Abstract][Full Text] [Related]
56. Telomerase as a useful target in cancer fighting-the breast cancer case.
Holysz H; Lipinska N; Paszel-Jaworska A; Rubis B
Tumour Biol; 2013 Jun; 34(3):1371-80. PubMed ID: 23558965
[TBL] [Abstract][Full Text] [Related]
57. 9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells.
Sato N; Mizumoto K; Kusumoto M; Niiyama H; Maehara N; Ogawa T; Tanaka M
FEBS Lett; 1998 Dec; 441(2):318-21. PubMed ID: 9883907
[TBL] [Abstract][Full Text] [Related]
58. Novel agents in colorectal cancer.
Erlichman C
Tumori; 2001; 87(1 Suppl 1):S9. PubMed ID: 11300041
[No Abstract] [Full Text] [Related]
59. Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?
Ando K; Nakagawara A
Biomolecules; 2021 May; 11(5):. PubMed ID: 34069817
[TBL] [Abstract][Full Text] [Related]
60. Assessment of telomerase as drug target in breast cancer.
Jaiswal RK; Yadava PK
J Biosci; 2020; 45():. PubMed ID: 32515354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
